Comments in Response to Revision of the EU general pharmaceuticals legislation

Wednesday, April 28, 2021 - 10:00am

The Chamber and its Global Innovation Policy Center appreciate the opportunity to respond to the European Commission IIA on revision of general pharmaceuticals legislation, consistent with our ongoing support for the Commission’s work to remove trade barriers and protect IP.

Our comments are attached.